Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HighTower Advisors LLC cut its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 62.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 532,632 shares of the medical research company’s stock after selling 904,048 shares during the period. […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) – SVB Leerink boosted their Q2 2023 EPS estimates for shares of Exact Sciences in a report released on Wednesday, May 10th. SVB Leerink analyst P. Souda now expects that the medical research company will post earnings of ($0.51) per share for the quarter, up from their prior […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) General Counsel James Herriott sold 1,300 shares of the firm’s stock in a transaction that occurred on Wednesday, May 10th. The shares were sold at an average price of $79.85, for a total value of $103,805.00. Following the transaction, the general counsel now directly owns 8,564 shares of […]
NEW YORK — Stocks that traded heavily or had substantial price changes Wednesday: Airbnb Inc., down $13.88 to $113.19. The short-term rental giant gave investors a disappointing... | May 10, 2023
Exact Sciences (NASDAQ:EXAS – Get Rating) issued its quarterly earnings results on Tuesday. The medical research company reported ($0.42) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.79) by $0.37, Briefing.com reports. Exact Sciences had a negative net margin of 29.92% and a negative return on equity of 19.76%. The company had […]